TNFα
5'-CATCTTCTCAAAATTCGAGTGACAA-3' 5'-TGGGAGTAGACAAGGTACAACCC-3' CCL2 5'-ACTGAAGCCAGCTCTCTCTTCCTC-3' 5'-TTCCTTCTTGGGGTCAGCACAGAC-3' CCL5 5'-CCACTTCTTCTCTGGGTTGG-3' 5'-GTGCCCACGTCAAGGAGTAT-3' Conditioned media were collected from NIK-overexpressing αTC1-6 cells (NIKCM) and control cells (βGalCM). Half of NIKCM was neutralized with antibodies against TNFα, CCL2 and CCL5, denoted as NIKCM+Ab. INS-1 832/13 cells were treated with these conditioned media for 16 h. Cell viability was measured by MTT assays (A), and cell apoptosis was measured by TUNEL staining (B). A combination of TNFα (5 ng/mL), CCL2 (100 ng/mL) and CCL5 (100 ng/mL) were used to treat
